| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AKT inhibitor VIII | GDSC1000 | pan-cancer | AAC | -0.0089 | 0.8 |
| mRNA | dacarbazine | CTRPv2 | pan-cancer | AAC | 0.0084 | 0.8 |
| mRNA | AR-42 | GDSC1000 | pan-cancer | AAC | -0.0076 | 0.8 |
| mRNA | valdecoxib | CTRPv2 | pan-cancer | AAC | -0.0094 | 0.8 |
| mRNA | CHIR-99021 | GDSC1000 | pan-cancer | AAC | 0.0077 | 0.8 |
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | 0.013 | 0.8 |
| mRNA | MP470 | GDSC1000 | pan-cancer | AAC | 0.0082 | 0.8 |
| mRNA | FK866 | GDSC1000 | pan-cancer | AAC | 0.0072 | 0.8 |
| mRNA | KIN001-266 | GDSC1000 | pan-cancer | AAC | 0.0077 | 0.8 |
| mRNA | IPR-456 | CTRPv2 | pan-cancer | AAC | -0.009 | 0.8 |